Antibodies News and Research

RSS

A novel molecularly imprinted polypyrrole electrode for diagnosing COVID-19

A recent study examines the interaction between the SARS-CoV-2 spike glycoprotein through the use of a molecularly imprinted polypyrrole electrode.

12 Oct 2022

Study provides new insights into the origin and development of B cells

B cells and the antibodies they produce play an important role in our immune system, protecting us from the microscopic enemies that make us ill.

11 Oct 2022

What is the association of SARS-CoV-2 vaccination with the risk of PASC in patients with SARDs?

Findings of a new study depicted that fully vaccinated patients suffering from systemic autoimmune rheumatic diseases harbor a lower propensity to developing long COVID symptoms compared to SARDs patients who are not fully vaccinated.

11 Oct 2022

BNT162b2 COVID-19 booster vaccine induces robust humoral responses independent of the interval between the first two doses

A recent Cell Reports study evaluated humoral responses induced after the second and third doses of the mRNA vaccine.

11 Oct 2022

Study suggests colleagues and household members increase SARS-CoV-2 infection risk in hospital employees, not COVID-19 patients

In a new study, researchers conducted an observational study to assess severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence and infection status among Jena University Hospital (JUH) employees.

10 Oct 2022

Scientists explore kinetics of naturally induced anti-SARS-CoV-2 antibodies in the Kenyan population

In a new study, researchers investigated the breadth and longevity of immunity induced by natural severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure among the Kenyan population.

10 Oct 2022

Study uncovers how the TAZ protein protects hematopoietic stem cells from aging

A well-functioning immune system is essential for protection against infections. However, with increasing age, the functioning of the immune system diminishes, which is also due to age-related damage in hematopoietic (blood) stem cells.

7 Oct 2022

Study evaluates efficacy of a candidate SARS-CoV-2 subunit vaccine to protect endangered black-footed-ferrets

In a new study, researchers assessed the safety, efficacy, and immunogenicity of a candidate SARS-CoV-2 subunit vaccine in black-footed ferrets (BFF), and investigated the susceptibility of these endangered North American mammals to the virus.

7 Oct 2022

Vaccine-induced neutralizing and non-neutralizing antibody activity against SARS-CoV-2

A new study demonstrated that vaccine-induced antibody functions against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) diminish with age.

7 Oct 2022

Scientists investigate the antibody titers post-mRNA COVID-19 booster vaccine in the elderly

The coronavirus 2019 disease (COVID-19) pandemic has affected millions worldwide and claimed multiple lives.

6 Oct 2022

Clinical trials of novel COVID-19 vaccine developed in Brazil to begin soon

Testing on humans of a novel COVID-19 vaccine developed in Brazil will begin this year. It performed well in animal trials, as reported in an article published in August in Nature Communications.

6 Oct 2022

Impaired immune responses not responsible for COVID-19 rebound, findings suggest

Findings from a small study of eight patients published in Clinical Infectious Diseases suggest that COVID-19 rebound is likely not caused by impaired immune responses.

6 Oct 2022

Intranasal vaccine represents an effective broad-spectrum COVID-19 vaccine strategy

Researchers evaluated the efficacy of dNS1-RBD, a novel intranasal COVID-19 vaccine.

6 Oct 2022

$The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series$

The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series

Researchers evaluated the vaccine effectiveness of half-doses of AZD1222 or BNT162b2 COVID-19 vaccines as a booster dose following primary series vaccination with CoronaVac.

6 Oct 2022

Antibodies News and Research

A novel molecularly imprinted polypyrrole electrode for diagnosing COVID-19

Study provides new insights into the origin and development of B cells

What is the association of SARS-CoV-2 vaccination with the risk of PASC in patients with SARDs?

BNT162b2 COVID-19 booster vaccine induces robust humoral responses independent of the interval between the first two doses

Study suggests colleagues and household members increase SARS-CoV-2 infection risk in hospital employees, not COVID-19 patients

Scientists explore kinetics of naturally induced anti-SARS-CoV-2 antibodies in the Kenyan population

Study uncovers how the TAZ protein protects hematopoietic stem cells from aging

Study evaluates efficacy of a candidate SARS-CoV-2 subunit vaccine to protect endangered black-footed-ferrets

Vaccine-induced neutralizing and non-neutralizing antibody activity against SARS-CoV-2

Scientists investigate the antibody titers post-mRNA COVID-19 booster vaccine in the elderly

Clinical trials of novel COVID-19 vaccine developed in Brazil to begin soon

Impaired immune responses not responsible for COVID-19 rebound, findings suggest

Intranasal vaccine represents an effective broad-spectrum COVID-19 vaccine strategy

The immune responses and safety of fractional third-doses of heterologous COVID-19 vaccines after CoronaVac primary series

Transient cell-in-cell formation by tumor cells found to build resistance to immunotherapy

Yeast display used to generate SARS-CoV-2 RBD-specific nanobodies

Study reveals the determinants of persistent and severe COVID-19

Myocarditis may be attributable to monkeypox infection

Omicron reduces host antibody response by lower B-cell antigenicity

Antibody escape mutations of SARS-CoV-2 BA.2.75

A new way of characterising biomolecules eBook

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest Life Science News